Literature DB >> 15461039

Heat loss and continuous renal replacement therapy.

Susan Jones1.   

Abstract

Because of the devastating consequences of thermal imbalance, it is imperative that nurses understand these concepts and apply them to the daily care of their patients. Heat loss, heat conservation, and heat generation interplay to maintain the narrow range that is considered optimal for human cellular function. These concepts factor into patients who are critically ill but are especially important for patients undergoing continuous renal replacement therapy. Many of these types of dialysis expose the individual patient's blood to room temperature dialysate via an extracorporeal circuit 24-hours a day, sometimes for several weeks at a time. Critical care and advanced practice nurses must understand the interplay of the processes of heat loss, conservation, and heat generation to ensure patients undergoing this therapy achieve maximum benefit with the fewest complications possible.

Entities:  

Mesh:

Year:  2004        PMID: 15461039     DOI: 10.1097/00044067-200404000-00008

Source DB:  PubMed          Journal:  AACN Clin Issues        ISSN: 1079-0713


  2 in total

1.  Lactate clearance is associated with mortality in septic patients with acute kidney injury requiring continuous renal replacement therapy: A cohort study.

Authors:  Rogério da Hora Passos; Joao Gabriel Rosa Ramos; André Gobatto; Evandro José Bulhões Mendonça; Eva Alves Miranda; Fábio Ricardo Dantas Dutra; Maria Fernanda R Coelho; Andrea C Pedroza; Paulo Benigno Pena Batista; Margarida Maria Dantas Dutra
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

2.  First 24-Hour Potassium Concentration and Variability and Association with Mortality in Patients Requiring Continuous Renal Replacement Therapy in Intensive Care Units: A Hospital-Based Retrospective Cohort Study.

Authors:  I-Chieh Mao; Pei-Ru Lin; Shin-Hwar Wu; Hsin-Hui Hsu; Pei-Shan Hung; Chew-Teng Kor
Journal:  J Clin Med       Date:  2022-06-13       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.